Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CDC42 | P60953 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840650 | 0.82 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E | |
| SCHEMBL19215377 | 0.80 | ALDH1A1 (0.78) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E | |
| SCHEMBL15836662 | 0.75 | ALDH1A1 (0.59) | ALDH1A1CYP1A2CYP2C19KDM4EHPGD | |
| SCHEMBL15840669 | 0.75 | KMT2A (0.74) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E | |
| SCHEMBL25893857 | 0.75 | NPC1 (0.81) | ALDH1A1HPGDLMNAKMT2AMEN1 | |
| SCHEMBL15840643 | 0.73 | ALDH1A1 (0.57) | ALDH1A1CYP1A2CYP2C19CYP2C9HPGD | |
| SCHEMBL15840642 | 0.73 | KMT2A (0.71) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E | |
| SCHEMBL17166027 | 0.71 | CDC42 (0.66) | ALDH1A1CYP1A2CYP2C19KDM4EHPGD | |
| SCHEMBL15840803 | 0.71 | PPIA (0.62) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E | |
| SCHEMBL15840800 | 0.71 | KMT2A (1.00) | ALDH1A1CYP1A2CYP2C19CYP2C9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | Errico, Joseph P. (US) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | EGFR, ERBB2, ERBB3 | ALDH1A1 4348/4885CYP1A2 3985/4885CYP2C19 3439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.